The ASCO Post captured initial reactions to the Oncologic Drugs Advisory Committee (ODAC) recommendation that the breast cancer indication for bevacizumab (Avastin) be revoked in interviews with ODAC voting members, breast cancer specialists, oncologists in private practice, third-party payers, and a patient advocate....
Read more...
This year more than 100,000 Australians will be told they have cancer. In her new book, oncologist Ranjana Srivastava says not all will get the medical treatment they deserve. She speaks to Julia Medew.
Read more...
Additional shows airing during premiere week feature three major themes which will recur throughout the year - "5 to Know," "Just 10 Pounds" and "The Pulse."
Read more...
Radiation therapy following surgery for a rare type of breast cancer improves patient survival, according to a study by a team of surgical oncologists at UC Davis Cancer Center.
Read more...
Mutations in the BRCA1 and BRCA2 genes raise the lifetime risk of breast cancer to as much as 84% and of ovarian cancer to as much as 63%.
Read more...
Cloaking devices helped Doctor Who's Tardis blend in, allowed the toothy on-screen Predator to elude Arnold Schwarze-negger, and let Klingon Birds of Prey slalom around Captain Kirk's photon torpedoes.
Read more...
Cancer specialists and charities rejected the claim by NICE that Avastin only prolongs lives by an average six weeks as 'spurious'.
Read more...